跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
趙 瑞益
教授
國立陽明交通大學
智慧型藥物與智能生物裝置研究中心
https://orcid.org/0000-0001-7671-3072
h-index
h10-index
h5-index
3201
引文
27
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
525
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
138
引文
5
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2024
每年研究成果
概覽
指紋
網路
計畫
(27)
研究成果
(78)
獎項
(1)
活動
(1)
類似的個人檔案
(6)
指紋
查看啟用 Jui-I Chao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Nanodiamond
100%
Survivin
81%
Apoptosis
72%
Securin
72%
Cytotoxicity
63%
Colorectal Cancer Cells
60%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
55%
Cancer Cells
52%
Induced Apoptosis
42%
Paclitaxel
38%
Carboxylated Nanodiamond
37%
Oxaliplatin
35%
Fluorescent Nanodiamonds
35%
Epidermal Growth Factor Receptor
34%
Cadmium
33%
Human Colorectal Cancer
32%
Protein Expression
31%
Tumor Inhibition
30%
P53 Pathway
30%
Cancer Cell Death
29%
Survivin Protein
28%
Biocompatibility
28%
Human Lung Carcinoma Cells
26%
Cdc2
24%
Cell Growth Inhibition
22%
Cetuximab
22%
Phosphorylation
22%
Growth Inhibition
22%
Protein Level
21%
H2AX
21%
Lung Carcinoma Cells
21%
Mitotic Catastrophe
21%
Autophagy Receptor
21%
Blockage
21%
Biolabeling
21%
Drug Delivery
20%
Celecoxib
20%
Cancer Therapy
20%
Anticancer Activity
20%
Cell Migration
19%
Gefitinib
19%
Chloro
19%
Cell Death
19%
Breast Cancer
19%
Selective Autophagy
19%
Arsenite (AsIII)
19%
Nanoparticles
18%
Cell Growth
18%
Cell Growth & Apoptosis
18%
Nanometer-sized
18%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
97%
Survivin
90%
Colorectal Carcinoma
87%
Protein P53
83%
Securin
71%
Nanodiamond
71%
Cytotoxicity
59%
Mitogen Activated Protein Kinase P38
50%
Lung Carcinoma
44%
Epidermal Growth Factor Receptor
43%
Lung Cancer
39%
Paclitaxel
37%
Oxaliplatin
35%
Cancer Inhibition
30%
Nanoparticle
27%
Gefitinib
26%
Carcinogenesis
24%
Neoplasm
22%
Cetuximab
22%
Non Small Cell Lung Cancer
20%
Phosphotransferase
20%
Celecoxib
20%
Colon Carcinoma
19%
Breast Cancer
18%
Arsenous Acid
18%
Arsenite
18%
Chinese Hamster
17%
Reactive Oxygen Metabolite
17%
Nitric Oxide
17%
Baicalein
17%
Caspase 3
16%
Tumor Growth
14%
Receptor
14%
Catalase
13%
Amitrole
13%
Nanomaterial
13%
Anticarcinogen
12%
Confocal Microscopy
12%
Breast Tumor
12%
Combination Therapy
12%
Cell Viability
11%
Proteasome
11%
S-Nitroso-N-Acetylpenicillamine
11%
Nude Mouse
10%
Quercetin
10%
Mutagenicity
10%
Disease
10%
Nanocomposite
10%
Cardiovascular Disease
9%
Drug Resistance
9%
